Michael Hall, laureate of the Charles Rodolphe Brupbacher Prize for Cancer Research 2019. (Image: Matthew Lee, Biozentrum)
Michael Hall of the Biozentrum of the University of Basel is awarded the Charles Rodolphe Brupbacher Prize for Cancer Research 2019. The prize recognizes his discovery of the TOR enzyme which controls cell growth via a complex signalling network. His work has made a key contribution to the development of new cancer drugs. The award ceremony will take place on 31 January 2019 in Zurich. The prize worth 100,000 Swiss francs, established by Frédérique Brupbacher in memory of her husband Charles Rodolphe Brupbacher, will be awarded for the 14 th time in January 2019, and is one of the most renowned awards for scientists working in cancer research world-wide. In 2019 the award will be presented to Michael Hall, Professor of Biochemistry at the University of Basel's Biozentrum, for his fundamental discovery of the basic mechanism of cell growth control and how this contributes to cancer development. Central control of cell growth discovered.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.